Table 2.
Demographic characteristics of study subjects.
| Cases (n = 235) | Controls (n = 252) | p values | |
|---|---|---|---|
| Age | 69.43 ± 9.33 | 68.37 ± 8.47 | 0.238 |
| PSA | 35.53 ± 53.74 | 8.76 ± 9.25 | <0.001 |
| BMI | 23.76 ± 8.13 | 22.32 ± 8.56 | 0.352 |
| Gleason score | |||
| <6 (3 + 3) | 86 (36.6%) | — | |
| 7 (3 + 4, 4 + 3) | 71 (30.2%) | — | |
| 8 (4 + 4) | 42 (17.9%) | — | |
| 9-10 (4 + 5, 5 + 4, 5 + 5) | 36 (16.3%) | — | |
| Prognosis stage | |||
| Stage I | 78 (33.2%) | — | |
| Stage II | 85 (36.2%) | — | |
| Stage III | 46 (19.6%) | — | |
| Stage IV | 26 (11.0%) | — |